Verition Fund Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-10,769
Closed -$30K – 3217
2022
Q3
$30K Sell
10,769
-190
-2% -$461 ﹤0.01% 2747
2022
Q2
$13K Buy
+10,959
New +$18.4K ﹤0.01% 2246

Verition Fund Management's ZY Position: Q4 2022 in Review

Verition Fund Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 10,769 shares — an estimated $30K sold.

Verition Fund Management first reported a position in ZY in Q2 2022 and held it in 2 quarters. The position peaked at $30K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Verition Fund Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 10,769 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $30K.
  • Verition Fund Management first reported a position in Zymergen Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Verition Fund Management's Zymergen Inc. Common Stock position peaked at $30K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.